Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Pacific Daily journalist was involved in the writing and production of this article.
Boole Microcap Fund Increased by 36.5% in 2022
The Boole Microcap Fund is a limited partnership that uses a quantitative investment strategy to beat the market over time.
They invest in quantitatively attractive microcap stocks based on cheapness, improving fundamentals, high insider ownership, high ROE, low debt, and similar criteria. This combination, in a focused portfolio, should beat the market over time.
The mission of the Boole Microcap Fund is to outperform the S&P 500 Index by at least 8% per year (net of fees) over rolling 5-year periods. They also aim to outpace the Russell Microcap Index by at least 2% per year (net) over rolling 5-year periods.
Boole Microcap Fund Performance Since Inception (June 9, 2020):
Boole Microcap Fund Russell Microcap S&P 500
2022 net return 36.5% -22.9% -20.0%
2021 net return 42.0% 18.3% 28.8%
2020 net return from inception  12.7% 31.7% 16.3%
Compounded annual return (net) 29.7% 6.3% 6.2%
Overall gain (net) 118.4% 20.1% 19.9%
 2020 net return is from inception June 9, 2020
5-Star Testimonials Include:
“I invested a couple of years ago in the Boole Microcap Fund and since then my investment has more than doubled even while the overall market has been flat.” Michael Myette, MD
“Want to maximize your returns when it comes to value investing? Then Jason is your man. Why? Because he knows the theory and practice of microcap stock investing. Plus, here’s the kicker. His fund went up by 36.5% in 2022 despite the market drop of 20%. By default he puts more money in your pockets. You have nothing to lose and everything to gain by working with him.” Kyle R. Bell
About Jason Bond
Jason Bond has been investing since 2009 and launched the Boole Microcap Fund in June, 2020. Mr. Bond taught Managerial Economics and Investments as an adjunct professor at Seattle University, 2013-2015 (4 courses).
Prior to that, he worked at Bond Financial in Seattle, Tortoise Investment Management in New York, and a boutique strategy consulting firm in Seattle. Previously, he played professional basketball in Belgium for two years. Mr. Bond earned a master’s degree in Economics from the University of Pennsylvania, and graduated magna cum laude from Gonzaga University with an Honors B.A. in Philosophy.
According to Jason, “Since inception (June, 2020), the Boole Microcap Fund is up 118.4% versus 20.1% for the Russell Microcap Index and 19.9% for the S&P 500 Index.”
Boole Microcap Fund
Experience Improved Quality of Life with Regenerative Medicine Treatments from QC Kinetix (Kennett Square), A Reliable Pain Control Clinic
Spread the love Kennett Square, PA – QC Kinetix (Kennett Square) is a regenerative medicineRead More
QC Kinetix (Brandon) is Using Regenerative Medicine as an Alternative to Surgery For Chronic Pain and Sports Injuries in Brandon, FL
Spread the love Brandon, FL – QC Kinetix (Brandon) uses regenerative medicine treatments to treatRead More